The world's leading specialist in medical laser technology, biolitec®, presents HOLA™ laser therapy for myomas and polyps at Medica 2013 - Ceralas® HPD or Leonardo® laser by biolitec® are used for outpatient treatment in gynecology - Gentle and side-effect-free alternative to conventional methods
Jena, 21 November 2013 - In Europe, about every fourth to sixth woman of childbearing age suffers from myomas. Due to the new laser therapy HOLA™, young women who desire to have child as well as older women now have a better option for surgery on the uterus.
Being a very gentle alternative to conventional methods, the innovative laser therapy HOLA™ (Hysteroscopic Outpatient Laser Applications) of biolitec® treats myomas in an outpatient setting and under local anesthesia with the Ceralas® HPD laser or the new Leonardo® Dual Laser. This is a significant advantage over the present state of the art, for example over using electrosurgical tools or similar older surgical techniques which often cause scars in the uterus or seizures as a result of electrical currents during the treatment. The painless laser procedure of biolitec® can be used against polyps as well.
The biolitec® laser therapy HOLA™ with its new diode laser provides a specific advantage by using standard instruments (e.g. hysteroscope) in combination with high-tech optical fibers that can be used directly in medical practice. Due to the specially developed laser fiber the contact vaporization of myomas or polyps leads to immediately visible results.
The specific wavelength of the laser allows controlled and precise working which minimizes intra-operative bleedings. The tissue is precisely vaporized by the innovative PolyFiber™ or MyoFiber™, and the deeper tissue remains untouched. The hysteroscopic vaporesection has no effect on the endometrium and also allows the treatment of larger myomas.
Attending doctors are convinced by the easy integration of the biolitec® HOLA™ laser therapy. Due to the excellent hemostasis and rapid tissue vaporization, inpatient time and postoperative discomforts are being reduced. biolitec®´s laser therapy is simple and straightforward in use. As an outpatient treatment, it saves time and money and quickly restores the patient’s pain-free life.
Currently, biolitec® is developing a new application within the field of laser-based sterilization of women. With a precisely controlled insertion of a biolitec® optical fiber into the fallopian tubes and with the targeted disruption of the organic functions by using laser energy, excellent results are being achieved. This process also offers significant advantages over conventional methods. The new therapy is currently being tested in a study on long-term success rates.
biolitec® is one of the leading companies worldwide in the field of medical laser treatments and the only provider that possesses all relevant core competencies – photosensitizers, laser devices and optical fibers – in the field of photodynamic therapy (PDT). Besides laser treatment of cancer with Foscan®, biolitec® primarily researches on minimally-invasive and gentle laser treatments and markets them. ELVeS Radial™ (Endo Laser Vein System) is the laser system most often used worldwide for the treatment of varicose veins. Ceralas® HPD laser therapy enables a gentle treatment of e.g. benign prostatic hyperplasia (BPH) in urology. Gentle laser treatments in the fields of proctology, ENT, orthopedics, gynecology as well as ophthalmology also belong to the business field of biolitec®. Further information at www.biolitec.com.
Telephone: +49 (0) 6172-27159-20
Telefax: +49 (0) 6172-27159-69